Posted inBusiness

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

March 8, 2024No Comments

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.

Pam Belluck
Author: Pam Belluck

Last updated on March 8, 2024

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.